Department of Hematology, Oncology and Palliative Care, Rems-Murr-Hospital, Winnenden, Germany.
Medical Department I, University Hospital Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
Ann Hematol. 2020 Dec;99(12):2723-2729. doi: 10.1007/s00277-020-04255-4. Epub 2020 Sep 15.
Despite the increasing role of molecular markers, differential counts and morphology of hematopoietic cells in the bone marrow (BM) remain essential diagnostic criteria in hematological diseases. However, the respective reference values for BM myelogram commonly used came from small series with limited numbers of healthy individuals. We evaluated the myelograms of 236 healthy individuals who underwent unrelated bone marrow donation. Health check-ups were performed 4 weeks prior to harvest. Samples for this study, taken from the first aspiration, were stained according to the standard Pappenheim method. Three experienced investigators assessed cellularity, megakaryopoiesis, and differential counts independently. The median donor age was 31 (range 18-51) years. Predonation tests did not reveal any relevant morbidity. Thirty-seven out of 42 hypocellular marrow samples were from younger donors up to 39 years. Content of megakaryocytes was normal in 210 specimens (89%). Gender and body mass index had significant impact on hematopoiesis, whereas age had not. The number of erythroblasts was higher (about 32%) and the proportion granulopoiesis slightly lower (about 50%) compared with previous studies. Differential counts showed also some differences with respect to individual maturation stages in these lines. Interrater comparisons showed greater reliability for the assignment of cells to the different hematopoietic cell lines than for single-cell diagnoses. This study largely confirms the results for cell counts in normal human bone marrow available from previous reports and provides some insights into factors that affect individual cell populations. It also reveals substantial variability among even experienced investigators in cytological diagnoses.
尽管分子标志物的作用不断增加,但骨髓(BM)中造血细胞的差异计数和形态仍然是血液病诊断的重要标准。然而,通常用于骨髓涂片的参考值来自于小系列的健康个体,数量有限。我们评估了 236 名进行无关骨髓捐献的健康个体的骨髓涂片。在采集前 4 周进行健康检查。本研究的样本取自第一次抽吸,根据标准的巴氏染色法染色。三名经验丰富的研究人员独立评估细胞计数、巨核细胞生成和差异计数。供体的中位年龄为 31 岁(范围 18-51 岁)。 预捐测试未发现任何相关发病率。37 份低细胞骨髓样本来自 39 岁以下的年轻供体。210 份标本的巨核细胞含量正常(89%)。性别和体重指数对造血有显著影响,而年龄没有。与之前的研究相比,红细胞数量较高(约 32%),粒细胞生成比例略低(约 50%)。 与个体成熟阶段相比,差异计数在这些谱系中也显示出一些差异。评分者间比较表明,与单个细胞诊断相比,将细胞分配到不同的造血细胞谱系具有更高的可靠性。本研究在很大程度上证实了先前报告中关于正常人骨髓细胞计数的结果,并提供了一些关于影响个体细胞群的因素的见解。它还揭示了即使是经验丰富的研究人员在细胞学诊断方面也存在很大的差异。